ACADIA Pharmaceuticals
ACAD
#4034
Rank
C$4.24 B
Marketcap
C$24.54
Share price
-2.73%
Change (1 day)
-26.14%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2026 (TTM): C$2.94

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$3.05. In 2025 the company made an earnings per share (EPS) of C$3.33 an increase over its 2024 EPS that were of C$1.95.

EPS history for ACADIA Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$2.94-11.53%
2025C$3.3370.59%
2024C$1.95-457.89%
2023C-$0.54-71.64%
2022C-$1.9227.62%
2021C-$1.51-41.67%
2020C-$2.5812.5%
2019C-$2.29-17.95%
2018C-$2.80-17.02%
2017C-$3.370.43%
2016C-$3.3643.56%
2015C-$2.3473.4%
2014C-$1.35
2012C-$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.58 213.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.02-66.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.30 1,350.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.48 112.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
C-$6.63-316.90%๐Ÿ‡บ๐Ÿ‡ธ USA